Dominik Wodarz

Dominik Wodarz's AcademicInfluence.com Rankings

Dominik Wodarz

Biology

#13516

World Rank

#17064

Historical Rank

Evolutionary Biology

#329

World Rank

#353

Historical Rank

Ecology

#837

World Rank

#907

Historical Rank

Genetics

#1511

World Rank

#1614

Historical Rank

biology Degrees

Download Badge

Biology

Dominik Wodarz's Degrees

PhD Biological Sciences University of California, Irvine
Masters Biological Sciences University of California, Irvine
Bachelors Biological Sciences University of California, Irvine

Why Is Dominik Wodarz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dominik Wodarz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Drug resistance in cancer: principles of emergence and prevention. (2005) (369)
Compromised Influenza Virus-Specific CD8+-T-Cell Memory in CD4+-T-Cell-Deficient Mice (2002) (332)
Role of CD8+ Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment (2001) (290)
Mathematical models of HIV pathogenesis and treatment. (2002) (264)
Specific therapy regimes could lead to long-term immunological control of HIV. (1999) (262)
Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. (2015) (193)
Viruses as antitumor weapons: defining conditions for tumor remission. (2001) (181)
Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses. (2003) (165)
Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment (2000) (163)
Multiploid Inheritance of HIV-1 during Cell-to-Cell Infection (2011) (162)
Computational Biology of Cancer: Lecture Notes and Mathematical Modeling (2005) (151)
The importance of lytic and nonlytic immune responses in viral infections. (2002) (147)
Persistent Virus Infection despite Chronic Cytotoxic T-Lymphocyte Activation in Gamma Interferon-Deficient Mice Infected with Lymphocytic Choriomeningitis Virus (2000) (137)
Killer cell dynamics : mathematical and computational approaches to immunology (2007) (125)
The 2019 mathematical oncology roadmap (2019) (124)
Evolutionary dynamics of feedback escape and the development of stem-cell–driven cancers (2011) (113)
Dynamics of Cancer: Mathematical Foundations of Oncology (2014) (111)
HIV–1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing? (2000) (109)
Helper-dependent vs. helper-independent CTL responses in HIV infection: implications for drug therapy and resistance. (2001) (107)
Tumor growth dynamics: insights into evolutionary processes. (2013) (106)
ODE models for oncolytic virus dynamics. (2010) (103)
The role of antigen-independent persistence of memory cytotoxic T lymphocytes. (2000) (100)
Direct quantitation of rapid elimination of viral antigen‐positive lymphocytes by antiviral CD8+ T cells in vivo (2000) (99)
The dynamics of HTLV-I and the CTL response. (1999) (95)
Effect of Cellular Quiescence on the Success of Targeted CML Therapy (2007) (92)
Dynamics of cytotoxic T–lymphocyte exhaustion (1998) (90)
Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL) (2014) (89)
A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment. (2000) (88)
Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agents. (2003) (86)
Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib. (2013) (85)
In Vivo HIV-1 Cell-to-Cell Transmission Promotes Multicopy Micro-compartmentalized Infection. (2016) (82)
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib. (2017) (76)
Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model Selection (2009) (76)
HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells (2016) (74)
The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer. (2004) (69)
Killer cell dynamics (2006) (66)
Complex Spatial Dynamics of Oncolytic Viruses In Vitro: Mathematical and Experimental Approaches (2012) (62)
Cytotoxic T–cell abundance and virus load in human immunodeficiency virus type 1 and human T–cell leukaemia virus type 1 (2001) (59)
Dynamics of macrophage and T cell infection by HIV. (1999) (59)
Virus dynamics in the presence of synaptic transmission. (2013) (58)
Virus dynamics: the effect of target cell limitation and immune responses on virus evolution. (1998) (56)
Boosting immunity by antiviral drug therapy: A simple relationship among timing, efficacy, and success (2003) (56)
Patterns of the COVID-19 pandemic spread around the world: exponential versus power laws (2020) (54)
Relative contribution of free-virus and synaptic transmission to the spread of HIV-1 through target cell populations (2013) (54)
Combination of Two but Not Three Current Targeted Drugs Can Improve Therapy of Chronic Myeloid Leukemia (2009) (53)
Defining CTL-induced pathology: implications for HIV. (2000) (53)
The role of T cell help for anti-viral CTL responses. (2001) (52)
Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. (1999) (50)
Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy. (2003) (47)
Evolutionary Dynamics of HTLV-I (1999) (45)
CD8 memory, immunodominance, and antigenic escape (2000) (44)
Immune Responses and Viral Phenotype: Do Replication Rate and Cytopathogenicity Influence Virus Load? (2000) (44)
Effect of stem cell turnover rates on protection against cancer and aging. (2007) (44)
Mathematical models of immune effector responses to viral infections: Virus control versus the development of pathology (2005) (43)
Can loss of apoptosis protect against cancer? (2007) (43)
An HIV-1 Replication Pathway Utilizing Reverse Transcription Products That Fail To Integrate (2013) (42)
Complex role of space in the crossing of fitness valleys by asexual populations (2014) (41)
Immune responses and the emergence of drug–resistant virus strains in vivo (2004) (40)
Synaptic transmission and the susceptibility of HIV infection to anti-viral drugs (2013) (40)
Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer. (2007) (38)
Transient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus. (2000) (38)
A dynamical perspective of CTL cross-priming and regulation: implications for cancer immunology. (2003) (37)
Infection dynamics in HIV-specific CD4 T cells: does a CD4 T cell boost benefit the host or the virus? (2007) (36)
Stem Cell Control, Oscillations, and Tissue Regeneration in Spatial and Non-Spatial Models (2013) (36)
Quantitative Analysis of Long-Term Virus-Specific CD8+-T-Cell Memory in Mice Challenged with Unrelated Pathogens (2003) (36)
The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination. (2002) (35)
Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques. (2000) (35)
Effect of the CTL proliferation program on virus dynamics. (2005) (35)
Host factors influencing viral persistence. (2000) (34)
Minimizing the risk of cancer: tissue architecture and cellular replication limits (2013) (34)
Depletion of CD4+ T Cells Precipitates Immunopathology in Immunodeficient Mice Infected with a Noncytocidal Virus (2001) (32)
Effect of different modes of viral spread on the dynamics of multiply infected cells in human immunodeficiency virus infection (2011) (32)
Ecological and evolutionary principles in immunology. (2006) (32)
Human immunodeficiency virus evolution towards reduced replicative fitness in vivo and the development of AIDS (2007) (31)
Emergence and prevention of resistance against small molecule inhibitors. (2005) (30)
Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus. (2007) (30)
Effect of Synaptic Transmission on Viral Fitness in HIV Infection (2012) (29)
Computational modeling approaches to the dynamics of oncolytic viruses (2016) (29)
Combination therapies against chronic myeloid leukemia: short-term versus long-term strategies. (2009) (28)
The effect of different immune responses on the evolution of virulent CXCR4–tropic HIV (1998) (27)
Targeted Cancer Treatment in Silico (2014) (25)
Does programmed CTL proliferation optimize virus control? (2005) (25)
Early infection and spread of a conditionally replicating adenovirus under conditions of plaque formation. (2012) (24)
Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells (2017) (24)
Evolutionary dynamics of giant viruses and their virophages (2013) (24)
Dynamics of Cellular Responses to Radiation (2014) (23)
Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment. (2000) (23)
Complex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses (2017) (23)
Use of oncolytic viruses for the eradication of drug-resistant cancer cells (2009) (22)
Patterns of the COVID19 epidemic spread around the world: exponential vs power laws (2020) (22)
Passenger mutations can accelerate tumor suppressor gene inactivation in cancer evolution (2017) (21)
Evolutionary dynamics of HIV‐induced subversion of the immune response (1999) (21)
Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation. (2008) (20)
Cellular Hierarchy as a Determinant of Tumor Sensitivity to Chemotherapy. (2017) (20)
Multiple Hiv-1 Infection of Cells and the Evolutionary Dynamics of Cytotoxic T Lymphocyte Escape Mutants (2009) (19)
HIV therapy: managing resistance. (2000) (19)
Perforin and IFN‐γ do not significantly regulate the virus‐specific CD8+ T cell response in the absence of antiviral effector activity (2004) (19)
Latency reversal plus natural killer cells diminish HIV reservoir in vivo (2022) (19)
Cancer: Risk factors and random chances (2015) (18)
Dynamics of killer T cell inflation in viral infections (2007) (18)
A weighted coenotic index (WCI): Description and application to soil animal assemblages (1992) (18)
Cancer-associated mutations in healthy individuals: assessing the risk of carcinogenesis. (2014) (18)
Utilizing alternate target cells in treating HIV infection through scheduled treatment (2004) (18)
Increased burst size in multiply infected cells can alter basic virus dynamics (2012) (17)
On the Laws of Virus Spread through Cell Populations (2014) (16)
Preventing clonal evolutionary processes in cancer: Insights from mathematical models (2015) (16)
Computational approaches to study oncolytic virus therapy : insights and challenges (2004) (16)
Evolution of Immunological Memory and the Regulation of Competition between Pathogens (2003) (16)
Dynamics of Cancer: Incidence, Inheritance, and Evolution.Princeton Series in Evolutionary Biology. BySteven A. Frank. Princeton (New Jersey): Princeton University Press. $99.50 (hardcover); $39.50 (paper). xiii + 378 p.; ill.; author and subject indexes. 978‐0‐691‐13365‐2 (hc); 978‐0‐691‐13366‐9 (p (2009) (15)
Heterogeneity in chronic myeloid leukaemia dynamics during imatinib treatment: role of immune responses (2010) (15)
Quantifying replicative senescence as a tumor suppressor pathway and a target for cancer therapy (2015) (15)
Infection of HIV-specific CD4 T helper cells and the clonal composition of the response. (2012) (15)
Genetic instability and the evolution of angiogenic tumor cell lines (review). (2001) (15)
Accelerated crossing of fitness valleys through division of labor and cheating in asexual populations (2012) (14)
Modeling multiple infection of cells by viruses: Challenges and insights. (2015) (14)
Characterizing inhibited tumor growth in stem-cell-driven non-spatial cancers. (2015) (14)
Effect of cellular de-differentiation on the dynamics and evolution of tissue and tumor cells in mathematical models with feedback regulation. (2018) (13)
Treatment interruptions to decrease risk of resistance emerging during therapy switching in HIV treatment (2007) (13)
Cytotoxic T-lymphocyte memory, virus clearance and antigenic heterogeneity (2001) (13)
Nearest-Neighbor Interactions, Habitat Fragmentation, and the Persistence of Host-Pathogen Systems (2013) (13)
Contrasting B cell- and T cell-based protective vaccines. (2005) (12)
Computational modeling approaches to studying the dynamics of oncolytic viruses. (2013) (12)
Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms. (2017) (12)
Immunity and protection by live attenuated HIV/SIV vaccines. (2008) (12)
Modeling T cell responses to antigenic challenge (2014) (11)
Effect of multiple infection of cells on the evolutionary dynamics of HIV in vivo: implications for host adaptation mechanisms (2011) (10)
CD4 T Cell Help (2007) (10)
A comprehensive in vivo and mathematic modeling-based kinetic characterization for aspirin-induced chemoprevention in colorectal cancer. (2020) (10)
Pyroptosis, superinfection, and the maintenance of the latent reservoir in HIV-1 infection (2017) (9)
On the emergence of multifocal cancers (2004) (9)
Methylation kinetics and CpG-island methylator phenotyope status in colorectal cancer cell lines (2013) (9)
Kinetics of chronic lymphocytic leukemia cells in tissues and blood during therapy with the BTK inhibitor ibrutinib (2014) (8)
Timing of CD8 T cell effector responses in viral infections (2016) (8)
Dependence of the Firearm-Related Homicide Rate on Gun Availability: A Mathematical Analysis (2013) (8)
Apparent competition and recovery from infection. (2004) (8)
New virus dynamics in the presence of multiple infection. (2015) (8)
Effect of aspirin on tumour cell colony formation and evolution (2017) (7)
Multiple infection of cells changes the dynamics of basic viral evolutionary processes (2018) (7)
Role of high-dose exposure in transmission hot zones as a driver of SARS-CoV-2 dynamics (2021) (7)
On the relative fitness of early and late stage Simian immunodeficiency virus isolates. (2007) (7)
Mechanisms underlying antigen-specific CD8+ T cell homeostasis. (2001) (7)
Dynamics of HIV Pathogenesis and Treatment (1999) (6)
Mutant Evolution in Spatially Structured and Fragmented Expanding Populations (2020) (6)
Checkpoint genes, ageing, and the development of cancer (2004) (6)
The role of telomere shortening in carcinogenesis: A hybrid stochastic-deterministic approach (2017) (6)
Virus and CTL dynamics in the extrafollicular and follicular tissue compartments in SIV-infected macaques (2018) (6)
Targeted cancer treatment: resisting arrest (2006) (6)
Modeling and control for in vitro combination therapy using ONYX-015 replicating adenovirus (2006) (6)
The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma. (2022) (6)
The Myogenesis Program Drives Clonal Selection and Drug Resistance in Rhabdomyosarcoma (2021) (5)
HIV dynamics and evolution (2002) (5)
Cellular replication limits in the Luria-Delbr\"uck mutation model (2015) (5)
Network models and the interpretation of prolonged infection plateaus in the COVID19 pandemic (2021) (5)
Mathematical models of HIV and the immune system. (2003) (5)
Quantifying the dynamics of viral recombination during free virus and cell-to-cell transmission in HIV-1 infection (2020) (4)
Effect of cell cycle duration on somatic evolutionary dynamics (2017) (4)
Mathematical models of HIV replication and pathogenesis. (2014) (4)
Role of high-dose exposure in transmission hot zones as a driver of SARS-CoV2 dynamics (2020) (4)
Genetic control and dynamics of the cellular immune response to HTLV-I (1999) (4)
Effect of feedback regulation on stem cell fractions in tissues and tumors: understanding chemoresistance in cancer. (2020) (4)
Aspirin and the chemoprevention of cancers: A mathematical and evolutionary dynamics perspective (2020) (4)
Editorial: Somatic evolution of cancer cells (2005) (4)
Cellular origins of cancer (2005) (3)
Drug resistance in acute viral infections: Rhinovirus as a case study (2006) (3)
Competition between genetically stable and unstable cells (2014) (3)
A call to arms: Unifying the fight against resistance (2018) (3)
Effect of Human Behavior on the Evolution of Viral Strains During an Epidemic (2021) (3)
Contribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus. (2015) (3)
Effect of synaptic cell-to-cell transmission and recombination on the evolution of double mutants in HIV (2019) (3)
Telomeres open a window on stem cell division (2016) (3)
Modeling the dynamics of COVID19 spread during and after social distancing (2020) (3)
Dynamical Interactions between Multiple Cancers (2005) (3)
Beyond the pair approximation: Modeling colonization population dynamics. (2020) (3)
Mathematical Modeling of Cyclic Cancer Treatments (2014) (2)
Determinants of stem cell enrichment in healthy tissues and tumors: implications for non-genetic drug resistance (2019) (2)
The Effects of Phenotypic Plasticity on the Fixation Probability of Mutant Cancer Stem Cells. (2020) (2)
System Biology Models and Conceptualizations Applied to Eco-Immunology (2014) (2)
The persistence of CTL memory. (2002) (2)
Dynamics of immune escape in HIV infection. (1999) (2)
Mathematical modeling of tumorigenesis (2005) (2)
Somatic Evolution of Cells and the Development of Cancer (2006) (2)
Mutant Evolution in Spatially Structured and Fragmented Expanding Populations. (2020) (1)
A hybrid stochastic-deterministic approach to explore multiple infection and evolution in HIV (2020) (1)
Adaptive Therapy and the Cost of Drug-Resistant Mutants (2021) (1)
Effect of Cellular Quiescence on the Evolution of Drug Resistance in CML (2014) (1)
Correspondence re: L. M. Wein et al., validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res., 63: 1317-1324, 2003. (2003) (1)
Methylation kinetics and CpG-island methylator phenotyope status in colorectal cancer cell lines (2013) (1)
Introduction to Oncolytic Viruses (2014) (1)
The persistence of CTL memory. Discussion (2002) (1)
Dynamical Interactions between CTL and Antibody Responses (2007) (1)
Calculating effective gun policies (2013) (1)
Genetic and Epigenetic Pathways to Colon Cancer Relating Experimental Evidence with Modeling (2008) (1)
Early Stochastic Dynamics in Human Cytomegalovirus Infection (2017) (1)
The role of migration in mutant dynamics in fragmented populations (2022) (1)
Combination Therapies: Short-Term Versus Long-Term Strategies (2014) (1)
Cancer as a microevolutionary process (2007) (1)
The role of migration in mutant evolution in fragmented populations (2021) (1)
Evolutionary dynamics of culturally transmitted, fertility-reducing traits (2019) (1)
Tissue architecture, feedback regulation, and resilience to viral infection. (2014) (1)
Basic Dynamics of Chronic Myeloid Leukemia During Imatinib Treatment (2014) (1)
Spatial dynamics of feedback and feedforward regulation in cell lineages (2021) (1)
The protective effect of aspirin in colorectal carcinogenesis: a multiscale computational study from mutant evolution to age incidence curves (2021) (1)
Mitotic Virus Transmission and Immune Responses (2014) (1)
Epigenetic changes and the rate of DNA methylation (2014) (0)
Title Accelerated crossing of fitness valleys through division of labor and cheating in asexual populations Permalink (2012) (0)
Spatial Oncolytic Virus Dynamics (2014) (0)
Background and Scope of the Book (2014) (0)
Microsatellite and chromosomal instability in sporadic and familial cancers (2005) (0)
Mathematical and Systems Medicine Approaches to Resistance Evolution and Prevention in Cancer (2021) (0)
Cytotoxic T-cell abundance and virus load in human immunode ciency virus type 1 and human T-cell leukaemia virus type 1 (2001) (0)
Infected with a Noncytocidal Virus Immunopathology in Immunodeficient Mice T Cells Precipitates + Depletion of CD4 (2001) (0)
Control versus CTL-Induced Pathology (2007) (0)
Spatial evolutionary dynamics of tumor initiation (2014) (0)
Two-species competition dynamics (2014) (0)
Latency reversal plus natural killer cells diminish HIV reservoir in vivo (2022) (0)
Role of High-Dose Exposure in Hot Zone Transmission as a Driver of SARS-CoV-2 Dynamics (2020) (0)
Tumor growth kinetics and disease progression (2014) (0)
Erratum for Wodarz et al., On the Laws of Virus Spread through Cell Populations (2014) (0)
Evolutionary dynamics of drug resistance in chronic myeloid leukemia (2014) (0)
Costs and benefits of chromosomal instability (2005) (0)
Increased burst size in multiply infected cells can alter basic virus dynamics (2012) (0)
Virus and CTL dynamics in the extra-follicular and follicular tissue compartments in SIV-infected macaques (2018) (0)
Modeling of HIV and CTL Response (2013) (0)
Evolutionary dynamics of tumor initiation through oncogenes: the gain-of-function model (2014) (0)
Supplemental Information for: Cellular replication limits in the Luria-Delbrück mutation model (2015) (0)
Laws of Spatially Structured Population Dynamics on a Lattice (2022) (0)
Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms (2016) (0)
Cross Resistance: Treatment and Modeling (2014) (0)
Therapeutic approaches: viruses as anti-tumor weapons (2005) (0)
Stochastic Modeling of Cellular Growth, Treatment, and Resistance Generation (2014) (0)
Evolutionary Dynamics of Drug Resistant Mutants in Targeted Treatment of CML (2014) (0)
Calculating eﬀective gun policies (2013) (0)
Effector Molecules and CTL Homeostasis (2007) (0)
Basic models of tumor inhibition and promotion (2005) (0)
Chromosomal instability and tumor growth (2014) (0)
Angiogenesis, inhibitors, promoters, and spatial growth (2014) (0)
Evolutionary dynamics of tumor initiation through tumor-suppressor genes: the loss-of-function model and stochastic tunneling (2014) (0)
Boosting Immunity against Immunosuppressive Infections (2007) (0)
DNA damage and genetic instability (2005) (0)
Calculating effective gun control policies (2013) (0)
Comment on: Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: Implications for virus design and delivery. Authors' reply (2003) (0)
Microsatellite and chromosomal instability in sporadic and familial colorectal cancers (2014) (0)
Modeling T cell responses to antigenic challenge (2014) (0)
Mutant evolution in spatially structured and fragmented populations (2019) (0)
Negative Feedback Regulation in Hierarchically Organized Tissues: Exploring the Dynamics of Tissue Regeneration and the Role of Feedback Escape in Tumor Development (2014) (0)
Telomeres and cancer protection (2014) (0)
Deterministic approximation for population dynamics in the presence of advantageous mutants (2022) (0)
Effect of cellular de-differentiation on the dynamics and evolution of tissue and tumor cells in mathematical models with feedback regulation (2017) (0)
Viruses and Immune Responses: A Dynamical View (2007) (0)
High Cell Death Rates at Start of Ibrutinib Therapy Predict for Deeper Remissions in Patients with Chronic Lymphocytic Leukemia (CLL) (2022) (0)
Axiomatic Approaches to Oncolytic Virus Modeling (2014) (0)
Effect of hot zone infection outbreaks on the dynamics of SARS-CoV-2 spread in the community at large (2020) (0)
UNIVERSITY OF CALIFORNIA, IRVINE Computational Models of Virus Dynamics DISSERTATION submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Ecology and Evolutionary Biology by (2015) (0)
Aspirin’s effect on kinetic parameters of cells contributes to its role in reducing incidence of advanced colorectal adenomas, shown by a multiscale computational study (2022) (0)
Host factors in(cid:143) uencing viral persistence (2003) (0)
Alterations of CNS structure & function by charged particle radiation & resultant oxidative stress (2010) (0)
Mutants escape from killer T cells, invade population (2003) (0)
Immune responses, tumor growth, and therapy (2014) (0)
Human immunodeficiency virus (HIV) dynamics in secondary lymphoid tissues and the evolution of cytotoxic T lymphocyte (CTL) escape mutants (2023) (0)
1070 Novel Mechanism of Aspirin-Mediated Chemoprevention Through Disruption of the PI3K-atk Axis in Colorectal Cancer (2016) (0)
HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells (2016) (0)
Towards higher complexities: social interactions (2014) (0)
Population Dynamics and Evolution of Cancer Cells (2018) (0)
Evolutionary dynamics of stem-cell driven tumor growth (2014) (0)
Correction for Wodarz and Levy, Human immunodeficiency virus evolution towards reduced replicative fitness in vivo and the development of AIDS (2008) (0)
Supplementary material from "Patterns of the COVID-19 pandemic spread around the world: exponential versus power laws" (2020) (0)
Basic Dynamics of Oncolytic Viruses (2014) (0)
Models of CTL Responses and Correlates of Virus Control (2007) (0)
Chan et al. 2016 Complete with supplementary data (2016) (0)
Mechanisms Underlying Antigen-Specific CD8 + T Cell Homeostasis (2001) (0)
Multiple Infections and CTL Dynamics (2007) (0)
Mechanisms of tumor neovascularization (2005) (0)
Title : Timing of CD 8 T cell effector responses in viral infections (2016) (0)
Supplementary material from "Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution" (2018) (0)
Evolutionary dynamics in hierarchical populations (2014) (0)
HIV therapy: Managing resi (2016) (0)
Cancer initiation: one-hit and two-hit stochastic models (2005) (0)
Mutant fixation in the presence of a natural enemy (2023) (0)
Single species growth (2014) (0)
Pathogens as biological tools in host competition. (2006) (0)
Lytic versus Nonlytic Activity (2007) (0)
Effect of feedback regulation on stem cell fractions in tissues and tumors: understanding chemo-resistance in bladder cancer (2019) (0)
Virus-Induced Subversion of CTL Responses (2007) (0)
Spatial evolution of regularization in learned behavior of animals. (2018) (0)
Chan-Levy 2016 supp figs (2016) (0)
Tissue aging and the development of cancer (2005) (0)
Pyroptosis, superinfection, and the maintenance of the latent reservoir in HIV-1 infection (2017) (0)
Cancer and immune responses (2005) (0)
Evolutionary Aspects of Immunity (2007) (0)
An Introduction to Small Molecule Inhibitors and Chronic Myeloid Leukemia (2014) (0)
Correction: Complex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses (2017) (0)
Gene therapy and oncolytic virus therapy (2014) (0)
Complex tumor dynamics in space (2014) (0)
Oncolytic Viruses and the Eradication of Drug-Resistant Tumor Cells (2014) (0)
S Y N T H E S E S Ecological and evolutionary principles in immunology (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dominik Wodarz?

Dominik Wodarz is affiliated with the following schools:

University of California, Irvine
University of Oxford

Dominik Wodarz's Academic­Influence.com Rankings

Dominik Wodarz's Degrees

Why Is Dominik Wodarz Influential?

Dominik Wodarz's Published Works

Published Works

What Schools Are Affiliated With Dominik Wodarz?

Dominik Wodarz's AcademicInfluence.com Rankings